Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net Income	$ 11,575	$ 9,024
Adjustments to reconcile net income to net cash flows (used in) provided by operating activities:
Change in deferred policy acquisition costs	(1,437)	3,369
Depreciation and amortization	6,359	5,711
Deferred income tax expense	822	2,704
Net realized (gains) losses	6	(2,423)
Loss on sale of subsidiary	0	477
Stock-based compensation expense	711	615
Amortization of premiums and accretions of discounts on investments	932	408
Non-controlling interest	62	(171)
Changes in operating assets and liabilities, net of the effects of acquisitions and dispositions:
Accrued investment income	(186)	39
Accounts and premiums receivable, net	(4,884)	(5,300)
Other receivables	(6,605)	8,152
Reinsurance recoverables	(2,444)	(527)
Other assets	(382)	559
Unpaid claims	(542)	(2,296)
Unearned premiums	3,185	6,558
Policyholder account balances	(1,817)	0
Accrued expenses, accounts payable, income taxes and other liabilities	15,340	(20,964)
Deferred revenue	(1,617)	(5,595)
Net cash flows provided by (used in) operating activities	19,078	340
Investing activities
Proceeds from maturities, calls and prepayments of available-for-sale investments	8,052	7,418
Proceeds from sales of available-for-sale investments	4,980	33,663
Proceeds from maturities of short term investments	100	100
Purchases of available-for-sale investments	(33,484)	(37,859)
Purchases of property and equipment	(5,174)	(5,411)
Net received (paid) for acquisitions of subsidiaries, net of cash received	(308)	(40,611)
Sale of subsidiary, net of cash paid	0	(153)
Net (issuance) proceeds from notes receivable	(678)	24
Change in restricted cash	(7,052)	6,043
Net cash flows used in investing activities	(33,564)	(36,786)
Financing activities
Payments on notes payable	(126,200)	(64,263)
Proceeds from notes payable	124,368	91,550
Payments for intial public offering costs	0	(827)
Payments on redeemable preferred stock	0	(10,940)
Net proceeds from exercise of stock options	19	651
Purchase of treasury stock	(3,923)	0
Net proceeds received from stock issued in the Employee Stock Purchase Plan	167	0
Net cash flows (used in) provided by financing activities	(5,569)	16,171
Net (decrease) in cash and cash equivalents	(20,055)	(20,275)
Cash and cash equivalents, beginning of period	31,339	43,389
Cash and cash equivalents, end of period	$ 11,284	$ 23,114